Cell Press Reviews: Stem Cells to Model and Treat Disease informs, inspires, and connects stem cell researchers and clinicians at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated by Cell Press editors. The publication offers a broad view of some of the most compelling topics in stem cell research including:
Contributions come from leading voices in the field, including: - Shinya Yamanaka, Recipient of the 2012 Nobel Prize for Physiology or Medicine, Recipient of the 2012 Millennium Technology Prize, Professor and Director of the Center for iPS Cell Research and Application at Kyoto University, Senior Investigator at the Gladstone Institute of Cardiovascular Disease, L.K. Whittier Foundation Investigator in Stem Cell Biology and Professor at the University of California, San Francisco - George Q. Daley, Samuel E. Lux IV Professor of Hematology/Oncology at Harvard Medical School and Director for the Stem Cell Transplantation Program at Boston Children’s Hospital - Irving Weissman, Member of National Academy of Sciences, Virgina & D.K Ludwig Professor for Clinical Investigation in Cancer Research, and Director for Institute of Stem Cell Biology and Regenerative Medicine at Stanford University of Medicine
Cell Press Reviews: Stem Cells to Model and Treat Disease is part of the Cell Press Reviews series, which features reviews published in Cell Press primary research and Trends reviews journals.
1. Cover image - p. Cover 2. Title page - p. Cover 3. Table of Contents - p. Cover 4. Copyright - p. Cover 5. About Cell Press - p. Cover 6. Contributors - p. Cover 7. Preface - p. Cover 8. Chapter 1. Stem Cell Therapies Could Change Medicine… If They Get the Chance - p. GXV 9. Chapter 2. Why Is It Taking So Long to Develop Clinically Competitive Stem Cell Therapies for CNS Disorders? - p. G6 10. Chapter 3. Assessing the Safety of Stem Cell Therapeutics - p. G13 11. Chapter 4. The Promise and Perils of Stem Cell Therapeutics - p. G34 12. Chapter 5. Reprogramming Cellular Identity for Regenerative Medicine - p. G56 13. Chapter 6. Cardiac Stem Cell Therapy and the Promise of Heart Regeneration - p. G82 14. Chapter 7. Next-Generation Regenerative Medicine: Organogenesis from Stem Cells in 3D Culture - p. G104 15. Chapter 8. Induced Pluripotent Stem Cells: Past, Present, and Future - p. G129 16. Chapter 9. Remodeling Neurodegeneration: Somatic Cell Reprogramming-Based Models of Adult Neurological Disorders - p. G145 17. Chapter 10. Therapeutic Translation of iPSCs for Treating Neurological Disease - p. G170 18. Chapter 11. Modeling Human Disease with Pluripotent Stem Cells: From Genome Association to Function - p. G196 19. Chapter 12. How Can Human Pluripotent Stem Cells Help Decipher and Cure Huntington’s Disease? - p. G224 20. Chapter 13. Integrating Human Pluripotent Stem Cells into Drug Development - p. G247 21. Chapter 14. Process Engineering of Human Pluripotent Stem Cells for Clinical Application - p. G266 22. Chapter 15. Mesenchymal Stem Cells: Therapeutic Outlook for Stroke - p. G286 23. Chapter 16. The Potential of Stem Cells as an In Vitro Source of Red Blood Cells for Transfusion - p. G301 24. Chapter 17. Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease - p. G314 25. Chapter 18. Stem Cells in Translation - p. G333 26. Index - p. G349
Cell Press Reviews: Stem Cells to Model and Treat Disease informs, inspires, and connects stem cell researchers and clinicians at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated by Cell Press editors. The publication offers a broad view of some of the most compelling topics in stem cell research including:
Contributions come from leading voices in the field, including: - Shinya Yamanaka, Recipient of the 2012 Nobel Prize for Physiology or Medicine, Recipient of the 2012 Millennium Technology Prize, Professor and Director of the Center for iPS Cell Research and Application at Kyoto University, Senior Investigator at the Gladstone Institute of Cardiovascular Disease, L.K. Whittier Foundation Investigator in Stem Cell Biology and Professor at the University of California, San Francisco - George Q. Daley, Samuel E. Lux IV Professor of Hematology/Oncology at Harvard Medical School and Director for the Stem Cell Transplantation Program at Boston Children’s Hospital - Irving Weissman, Member of National Academy of Sciences, Virgina & D.K Ludwig Professor for Clinical Investigation in Cancer Research, and Director for Institute of Stem Cell Biology and Regenerative Medicine at Stanford University of Medicine
Cell Press Reviews: Stem Cells to Model and Treat Disease is part of the Cell Press Reviews series, which features reviews published in Cell Press primary research and Trends reviews journals.
1. Cover image - p. Cover 2. Title page - p. Cover 3. Table of Contents - p. Cover 4. Copyright - p. Cover 5. About Cell Press - p. Cover 6. Contributors - p. Cover 7. Preface - p. Cover 8. Chapter 1. Stem Cell Therapies Could Change Medicine… If They Get the Chance - p. GXV 9. Chapter 2. Why Is It Taking So Long to Develop Clinically Competitive Stem Cell Therapies for CNS Disorders? - p. G6 10. Chapter 3. Assessing the Safety of Stem Cell Therapeutics - p. G13 11. Chapter 4. The Promise and Perils of Stem Cell Therapeutics - p. G34 12. Chapter 5. Reprogramming Cellular Identity for Regenerative Medicine - p. G56 13. Chapter 6. Cardiac Stem Cell Therapy and the Promise of Heart Regeneration - p. G82 14. Chapter 7. Next-Generation Regenerative Medicine: Organogenesis from Stem Cells in 3D Culture - p. G104 15. Chapter 8. Induced Pluripotent Stem Cells: Past, Present, and Future - p. G129 16. Chapter 9. Remodeling Neurodegeneration: Somatic Cell Reprogramming-Based Models of Adult Neurological Disorders - p. G145 17. Chapter 10. Therapeutic Translation of iPSCs for Treating Neurological Disease - p. G170 18. Chapter 11. Modeling Human Disease with Pluripotent Stem Cells: From Genome Association to Function - p. G196 19. Chapter 12. How Can Human Pluripotent Stem Cells Help Decipher and Cure Huntington’s Disease? - p. G224 20. Chapter 13. Integrating Human Pluripotent Stem Cells into Drug Development - p. G247 21. Chapter 14. Process Engineering of Human Pluripotent Stem Cells for Clinical Application - p. G266 22. Chapter 15. Mesenchymal Stem Cells: Therapeutic Outlook for Stroke - p. G286 23. Chapter 16. The Potential of Stem Cells as an In Vitro Source of Red Blood Cells for Transfusion - p. G301 24. Chapter 17. Hematopoietic-Stem-Cell-Based Gene Therapy for HIV Disease - p. G314 25. Chapter 18. Stem Cells in Translation - p. G333 26. Index - p. G349
